Design Therapeutics logo

Design Therapeutics

DSGN | NASDAQ
Chart Builder DCF Calculator
$9.92
-$0.55 (-5.25%)
At close: Nov 16, 2026, 4:00 PM ET
$9.92
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:10 PM ET
-5.25%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
16.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #1010/1021 (Top 99%)

Key Statistics

Market Data

Market Cap $635.24M
1D Range
9.77 10.46
52W Range
7.34 15.94

Valuation (TTM)

PE -8.27
PB 3.14
EV/EBITDA -5.53

Valuation (NTM)

Forward PE N/A
Forward PEG -4.29
Price Target $26.00
Loading financial charts...

Profile

Design Therapeutics, Inc. is a biopharmaceutical company in the preclinical phase that focuses on creating treatments for genetic conditions stemming from nucleotide repeat expansions. Its current pip...

Sector Healthcare
Industry Biotechnology
Employees 55
IPO Date Mar 29, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$26.00
Upside
+162.10%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.